Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT04321343 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG: PXL065
DRUG: Placebo oral tablet

Sponsor

Poxel SA